Leukemia Clinical Trials

Showing 1101-1120 of 10,987 trials

Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study

NCT07412041

The purpose of this study is to test the feasibility of the Precise Exercise Regimen for Cancer Care (PERCC) exercise program in participants with stage II-III primary lung cancer.

Stage II Lung CancerLung CancerNon-small Cell Lung Cancer+1 more

Dana-Farber Cancer Institute20 participantsStarted Jul 2026

TERMINATEDPhase 1

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

NCT05462873

To characterize safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of QEQ278 in adult patients with advanced/metastatic non-small cell lung cancer, esophageal squamous cell carcinoma, renal cell carcinoma, and human papilloma virus associated head and neck squamous cell carcinoma.

Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellEsophageal Squamous Cell Carcinoma+1 more

Novartis Pharmaceuticals30 participantsStarted Apr 2023

Los Angeles, California, United States • Fort Myers, Florida, United States • Boston, Massachusetts, United States +9 more locations

AVAILABLE

Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors

NCT06797362

The Expanded Access Program will provide an alternate mechanism for these patients, who lack satisfactory therapeutic alternatives and cannot participate in a zidesamtinib clinical trial, to access investigational zidesamtinib.

Non Small Cell Lung CancerROS1-positive Non-Small Cell Lung Cancer (NSCLC)

Nuvalent Inc.

Aurora, Colorado, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +32 more locations

Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors

Related Searches

Patient Perspectives of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Genomic BRCA and Extensive ovArian Cancer Testing

The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment

A Study of Single Dose of LP-003 in Adolescent Subjects

A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome

Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

Immune Nutrition in Pediatric Respiratory Allergy

Blood Storage Related Mortality and Adverse Effects in Trauma Patients

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease

RCT of EFTR Versus STER for GIST Treatment

Evaluating Methods to Replicate Stumbles and Slips During Walking

Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

Diagnostic and Therapeutic Efficacy and Safety of Enteroscopy in Pediatric Patients